Alloxan therapy for nesidioblastosis

Area of Science:

• Endocrinology
• Pediatric Surgery
• Medical Chemistry

Background:

• Nesidioblastosis is a rare pancreatic condition causing persistent hyperinsulinemic hypoglycemia.
• Subtotal pancreatectomy is a surgical option, but can lead to recurrent hypoglycemia.

Observation:

• Two pediatric patients with nesidioblastosis experienced recurrent hypoglycemia post-subtotal pancreatectomy.
• Conventional treatments were insufficient to manage the persistent hypoglycemia.

Findings:

• Successful treatment of recurrent hypoglycemia was achieved using alloxan (mesoxalyl urea).
• Alloxan demonstrated efficacy in controlling hyperinsulinemic hypoglycemia in these cases.

Implications:

• Alloxan represents a viable non-surgical therapeutic alternative for managing refractory nesidioblastosis.
• This approach may prevent the need for further, more debilitating surgical interventions in affected children.